Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beyond allergen avoidance: update on developing therapies for peanut allergy.

Xiu-Min Li1

  • 1Pediatric Allergy and Immunology, The Mount Sinai School of Medicine, New York, NY 10029-6574, USA. xiu-min.li@mssm.edu

Current Opinion in Allergy and Clinical Immunology
|May 3, 2005
PubMed
Summary

Novel treatments for peanut allergy are being developed beyond avoidance. Research shows promising results with immunotherapy and herbal medicine in animal models, offering hope for future therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The inhibition of pathological IgE in allergic diseases by natural compounds.

Natural products and bioprospecting·2026
Same author

Understanding Infantile Atopic Dermatitis: A Review of Environmental, Familial, Genetic and Microbial Influences.

Current allergy and asthma reports·2026
Same author

Cross-IgE sensitization correlates with cross-anaphylaxis among peanut and multiple tree nuts in a murine model.

Frontiers in allergy·2026
Same author

B cell development and longevity of IgE plasma cells.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same author

General commentary: 28-Day oral chronic toxicity study of arctigenin in rats.

Frontiers in pharmacology·2026
Same author

Ferroptosis-The "Double-Edged Sword" in Cancer: Mechanisms of Tumor Suppression/Resistance and Therapeutic Manipulation.

Biology·2026

Area of Science:

  • Allergy and Immunology
  • Immunotherapy
  • Pharmacology

Background:

  • Food allergy, particularly peanut allergy, is a growing health concern with increasing incidence in children.
  • Current management relies on strict allergen avoidance, which is often challenging and unsuccessful.
  • Fatal anaphylactic reactions underscore the urgent need for effective peanut allergy treatments.

Purpose of the Study:

  • To review and highlight promising novel therapeutic strategies for peanut allergy.
  • To explore treatment options beyond conventional allergen avoidance.
  • To assess recent advancements in peanut allergy management.

Main Methods:

  • Review of publications from 2003-2005 focusing on novel peanut allergy treatments.
  • Analysis of studies involving murine models of peanut anaphylaxis.

Related Experiment Videos

  • Evaluation of clinical trial data for anti-IgE antibody therapy.

    • Main Results:

    • Humanized recombinant anti-IgE antibodies showed potential in increasing allergic response thresholds but require continuous treatment.
    • Immunotherapy with engineered peanut protein and adjuvant demonstrated significant protection in mice.
    • A Chinese herbal medicine formula (Food Allergy Herbal Formula-2) completely blocked anaphylaxis in mice for up to 5 weeks.
    • Therapeutic effects were linked to the immunoregulation of Th1 and Th2 responses.

    Conclusions:

    • Despite the absence of a definitive safe and effective therapy, numerous novel approaches for food allergy are under investigation.
    • Emerging treatments, including immunotherapy and herbal medicines, show significant promise in preclinical models.
    • These novel strategies may offer effective treatment options for allergists in the near future.